Medical University of South Carolina
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Medical University of South Carolina sits in the top decile of US sponsors by registered trial count (#44 of 15,742 sponsors by registered trial count).
Medical University of South Carolina: 755 sponsored US clinical trials, 142 recruiting.
Medical University of South Carolina sponsors 755 registered US clinical trials on ClinicalTrials.gov, 142 of them currently recruiting, and 520 completed. 66 of these trials are in Phase 3-4 (later-stage) and 228 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Stroke, with 15 trials.
Top-decile sponsor footprint
Medical University of South Carolina ranks in the top decile of sponsors by registered trial count (#44 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
520 of 580 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (89.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
755 total, page 1 of 16
Omission of Postoperative Radiation in HPV-Associated Oropharyngeal Cancer Using ctHPVDNA Surveillance (OPERATION)
NCT07513389
Treatment of Depression Post-SCI
NCT04263285
CBD for Breast Cancer Primary Tumors
NCT06148038
Digitally Enhanced Stepped-Care for Depression in Primary Care
NCT07634705
Biologics in Chronic Rhinosinusitis With Nasal Polyposis
NCT06824649
Accelerated TMS for Apathy in PD
NCT07399496
At-home taVNS for Neurorehabilitation in Parkinson's Disease
NCT07536022
Evaluation of a Patient Decision Aid for Emergency Department Initiated Buprenorphine
NCT07278518
Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors
NCT07149207
Direct vs Standard SLT for Glaucoma: A Noninferiority Trial
NCT07408154
Sex Differences in Neurobehavioral Response to THC
NCT07225777
Mindfulness Training During Accelerated TMS for Depression
NCT07369557
Pilot of Mailing Buprenorphine
NCT07421102
Brain Stimulation and Cognitive Training for MCI
NCT07526740
Advanced Fibrosis Detection for MASLD in Primary Care
NCT07159386
Exoskeleton for Balance
NCT07356011
Cannabis Reduction and Functional Outcomes
NCT07218471
taVNS + CCT for Neurocognitive Rehab
NCT07517237
Add-On ZIDA Sock Therapy for Overactive Bladder
NCT07432659
Social Functioning in Opioid Use Disorder
NCT07044466
Tele-PCIT for Healthy Relationships in Families At-Risk
NCT07225010
The REPOSE (Reach for Equity in Pediatric Sleep Evaluation) Navigation Intervention
NCT06828835
Brain Metastases in Greater Size - Hypofractionated Options Trial (BIGSHOT)
NCT07227610
GLP1 Fasting Status and Gastric Retention Using Gastric Ultrasound
NCT07251803
Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer
NCT07325721
Behavioral Health Collaborative Care Model in Post-ICU Clinic Family Pilot
NCT07390786
Behavioral Health Collaborative Care Model in an ICU Recovery Clinic
NCT07372586
Feasibility of a Technology-Based Intervention for Depression Referral Uptake in Cancer Survivors
NCT07091968
SUPPORT-T in Patients With Progressive Pulmonary Fibrosis and Their Caregivers
NCT07269262
Methadone in THA for Post-op Pain and Opioid Reduction
NCT07227064
Methadone in TKA for Post-op Pain and Opioid Reduction
NCT07226076
Post-stroke Pain tAN-fMRI
NCT07144436
Text -Based Depression Screening Among Cancer Survivors
NCT06894849
Autophagy Maintenance (AUTOMAIN)
NCT06971744
Accelerated High-Dose tDCS for Depression
NCT07226011
Formoterol in Diabetes
NCT07022418
Transcutaneous Electrical Nerve Stimulation for Pain Mitigation During Intrauterine Device Placement
NCT06991075
BabySTrong II taVNS Feeding Trial
NCT07049952
Remimazolam vs Propofol in Laser Burn Cases
NCT07213544
Evaluating NALIRIFOX vs Modified Gemcitabine, Nab-Paclitaxel and Cisplatin in Patients With Locally Advanced and Metastatic Pancreatic Adenocarcinoma
NCT07076212
sTMS Combined With CIMT and taVNS In Infants With Hemiplegia
NCT07063446
Impact of Nd:YAG Laser Photobiostimulation on Healing of Gingiva
NCT07095556
Technology-Enhanced Therapy vs. Medication Monitoring for Buprenorphine Retention in Pregnant Persons
NCT06999811
Examining Whether Project Support Works
NCT06963554
Motoneuron Recruitment and Motor Evoked Potential Up-Conditioning (MEP) in Spinal Cord Injury (SCI)
NCT07179822
Closed-loop rTMS-EEG During Visuomotor Integration.
NCT07249801
Peripheral Nerve Stimulation With the SPRINT® System in Chronic PSIJC Pain
NCT07166952
Anthracycline-Free Neoadjuvant Chemoimmunotherapy for Triple Negative Breast Cancer Patients
NCT06845319
STEPS: Substance Use Trial of E-cigarettes or Pharmacotherapy for Smoking
NCT06922617
Functional Social Support in COPD Self-Management
NCT07353034
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 104 |
| Phase 2 | 124 |
| Phase 3 | 23 |
| Phase 4 | 43 |
Therapeutic Areas
What is open in the Medical University of South Carolina pipeline
142 recruiting of 755 indexed (19% open); 520 completed (69%).
Phase mix: 66 late (III/IV) vs 228 early (I/II) (early-phase heavy).
Top condition: Stroke (15 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Medical University of South Carolina: open-pipeline peers nationwide
Peers matched on 755 registered trials and 19% open enrollment, not the therapeutic-area sidebar.
Medical University of South Carolina sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 755 trials (± recruiting share)
- University of California, San Diego · 775 trials · 18% recruiting
- The University of Texas Health Science Center, Houston · 732 trials · 20% recruiting
- Dana-Farber Cancer Institute · 781 trials · 14% recruiting
- University of Miami · 721 trials · 20% recruiting
Sponsors near 19% open enrollment (± trial volume)
- Spaulding Rehabilitation Hospital · 19% recruiting · 101 trials
- Ipsen · 19% recruiting · 85 trials
- EyePoint Pharmaceuticals · 19% recruiting · 16 trials
- Hebrew SeniorLife · 19% recruiting · 32 trials
Related
What to do with this Medical University of South Carolina page
755 registered trials is a research-attention snapshot, not an endorsement of Medical University of South Carolina or any single study.
- 142 of Medical University of South Carolina's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Stroke is the condition Medical University of South Carolina studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Stroke trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Medical University of South Carolina pipeline card: 755 registered trials from official public datasets.Report a data error.